(Q33362127)

26 July 2017

Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. (English)

1 reference

Human T-lymphotropic virus 1

26 July 2017

0 references

2

Katherine P Theall

1 reference

26 July 2017

Mark A Beilke

1

1 reference

26 July 2017

Megan O'Brien

3

1 reference

26 July 2017

John L Clayton

4

1 reference

26 July 2017

Stephanie M Benjamin

5

1 reference

26 July 2017

Elsa L Winsor

6

1 reference

26 July 2017

Patricia J Kissinger

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

25 June 2004

1 reference

Clinical Infectious Diseases

26 July 2017

1 reference

26 July 2017

39

1 reference

26 July 2017

2

1 reference

26 July 2017

256-263

1 reference

Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases

26 July 2017

1 reference

An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users

21 January 2018

1 reference

Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.

21 January 2018

1 reference

High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland

21 January 2018

1 reference

The impact of human T-lymphotrophic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome

21 January 2018

1 reference

Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA.

21 January 2018

1 reference

Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users

21 January 2018

1 reference

Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil.

21 January 2018

1 reference

Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica.

21 January 2018

1 reference

Retroviral coinfections at a New Orleans HIV outpatient clinic.

21 January 2018

1 reference

HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1.

21 January 2018

1 reference

Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo

21 January 2018

1 reference

High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

21 January 2018

1 reference

Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2.

21 January 2018

1 reference

HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators

21 January 2018

1 reference

Longitudinal data analysis for discrete and continuous outcomes

21 January 2018

1 reference

Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States

21 January 2018

1 reference

Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals

21 January 2018

1 reference

Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1.

21 January 2018

1 reference

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/422146

1 reference

26 July 2017

1 reference